Neurosurgery Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The neurosurgery market is experiencing significant evolution with a focus on the development of advanced devices and techniques. With a projected market size of $5.34 billion in 2024 and expected to reach $7.58 billion by 2031, the market is anticipated to expand at a CAGR of 5.10%. A prominent segment within this market is neuro-interventional devices, indicating a trend toward minimally invasive procedures. This approach aims to reduce complications during surgery, utilizing specialized instruments like power tools, neurovascular embolization devices, and radiosurgery systems such as gamma-knife.

Manufacturers are launching innovative products to meet the increasing demand for high-quality neurosurgical tools. The market is witnessing advancements in technologies like robotics and minimally invasive surgeries, promising efficient and error-free results. The development of next-generation products is anticipated to facilitate faster recovery and less invasive procedures, driving market growth.

Leading manufacturers have introduced a diverse range of devices, focusing on regulatory approvals in key markets. The emphasis is on new solutions that incorporate cutting-edge technology to optimize treatment processes and improve patient outcomes. Enhanced regulatory standards and a growing incidence of neurological diseases are leading to the adoption of advanced treatment protocols. This trend is increasing the demand for neurosurgical services from both industry and government sectors.

Opportunities for Manufacturers

Technological advancements in the neurosurgery sector are creating significant opportunities for manufacturers. The shift from traditional to innovative technology-based equipment is notable, with newer techniques making neurosurgery more efficient. The adoption of endoscopic techniques, which require smaller incisions and lead to faster recovery times, exemplifies this progress.

Companies such as Adeor Medical AG, Stryker Corp, and B. Braun Melsungen AG are developing advanced neurosurgical drills and flexible neuroendoscopes. Innovations like Elekta's Esprit, which offers automated treatment planning and superior visualization, and Stryker's Surpass Evolve Flow Diverter, which promotes aneurysm healing, highlight the market's technological progression.

High adoption rates of these technologies are expected to fuel market expansion. Manufacturers are also investing in research and development to introduce cost-effective and advanced technologies. This focus on innovation is expected to enhance the acceptance and adoption of neurosurgeries, contributing to steady market growth.

Challenges in the Neurosurgery Market

The high cost of neurosurgical products and procedures is a significant challenge. Products like neurovascular embolization devices and neuroendoscopes are expensive, impacting hospitals and neurosurgical centers. Complex neurosurgeries, which require advanced techniques and skills, also incur high costs. The maintenance of facilities and continuous power supply further add to the service costs.

For example, decompressive craniotomy, a procedure to relieve pressure inside the skull, is notably costly. The lack of reimbursement policies for some procedures in regions like the U.S. and Europe exacerbates this issue, potentially hindering market growth.

Regional Insights

United States

The U.S. neurosurgery market is particularly attractive due to high healthcare expenditure. The focus on advanced technology to benefit neurological patients is driving market growth. Leading manufacturers are engaging in research and development to create novel products and secure FDA approvals, enhancing the market's value.

Germany

Germany's neurosurgery market benefits from extensive research and development, with a significant portion of clinical trials receiving government funding. Increased clinical trials in neurosurgery are enhancing safety and efficiency in managing neurological disorders, promoting market growth.

United Kingdom

The U.K. neurosurgery market is emerging as a prominent player, with a focus on achieving self-sufficiency and training specialized surgeons. The collaboration between neurosurgeons and other medical specialists is advancing the field, contributing to market growth.

Product and End User Insights

Neuro-interventional Devices

Neuro-interventional devices are driving global market growth due to their adoption in treating neurological disorders. Minimally invasive tools and techniques are favored for their quicker recovery times and less discomfort, contributing to their increased use.

Hospitals

Hospitals represent a significant end-user segment, with a large value share of the market. High surgeon and hospital volumes are associated with better outcomes for neurosurgical disorders, influencing the adoption of neurosurgical products and services.

Competitive Analysis

The competitive Analysis in the neurosurgery market is characterized by the development of technologically advanced products and strategic collaborations. Leading manufacturers are focusing on regulatory approvals and expanding their product portfolios through acquisitions and partnerships.

For instance, Boston Scientific's Vercise Genus Deep Brain Stimulation (DBS) System and Medtronic's acquisition of Intersect ENT are notable developments. Elekta's collaboration with IBA to optimize quality assurance in radiation therapy is another example of industry advancements.

Key Companies Profiled

B. Braun Melsungen AG
Medtronic plc
DePuy Synthes
Boston Scientific
Stryker Corp.
Terumo Corporation
KARL STORZ GmbH & Co KG
Integra LifeSciences
Penumbra Inc
Adeor Medical AG
Elekta
Clarus Medical
MACHIDA ENDOSCOPE CO., LTD.

Key Segments Covered in Neurosurgery Industry Research

Product Segments

Neuro Interventional Devices
- oNeurovascular Embolization Devices (Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips)
- oNeurovascular Coiling Assist Devices (Coiling Assist Stents, Coiling Assist Balloons)
- oNeurovascular Thrombectomy Devices (Stent Retrievers, Aspiration Retrievers)
- oMicroguidewires, Microcatheters, Support Catheters, Intracranial Stents
Neuroendoscopes (Flexible, Rigid)
Neurosurgical Drills (Pneumatic, Electrical)
Radiosurgery Systems (Linear Accelerator, Gamma Knife)
Dura Substitutes (Biological, Synthetic)
Neurosurgical Ablation Devices (MRI Guided Focused Ultrasound, MRI Guided Laser Therapy, MRI Guided RF Ablation)
Neurosurgery Instruments (Tissue Retractors, Forceps, Head Frames, Cervical Plating systems, Perforators)

End User Segments

Hospitals
Ambulatory Surgical Centers
Specialized Neurological Institutes

Regional Segments

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

1. Executive Summary

1.1. Global Neurosurgery Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2024
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Economic Overview
- 2.6.1. World Economic Projections
2.7. PESTLE Analysis

3. Global Neurosurgery Market Outlook, 2019-2031

3.1. Global Neurosurgery Market Outlook, by Product, Value (US$ Bn), 2019-2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Neuro Interventional Devices
    - 3.1.1.1.1. Neurovascular Embolization Devices
      - 3.1.1.1.1.1. Embolization Coils
      - 3.1.1.1.1.2. Liquid Embolic Systems
      - 3.1.1.1.1.3. Flow Diversion Stents
      - 3.1.1.1.1.4. Aneurysm Clips
    - 3.1.1.1.2. Neurovascular Coiling Assist Devices
      - 3.1.1.1.2.1. Coiling Assist Stents
      - 3.1.1.1.2.2. Coiling Assist Balloons
    - 3.1.1.1.3. Neurovascular Thrombectomy Devices
      - 3.1.1.1.3.1. Stent Retrievers
      - 3.1.1.1.3.2. Aspiration Retrievers
    - 3.1.1.1.4. Microguidewires
    - 3.1.1.1.5. Microcatheters
    - 3.1.1.1.6. Support Catheters
    - 3.1.1.1.7. Intracranial Stents
  - 3.1.1.2. Neuroendoscopes
    - 3.1.1.2.1. Flexible Neuroendoscopes
    - 3.1.1.2.2. Rigid Neuroendoscopes
  - 3.1.1.3. Neurosurgical Drills
    - 3.1.1.3.1. Pneumatic Neurosurgical Drills
    - 3.1.1.3.2. Electrical Neurosurgical Drills
  - 3.1.1.4. Radiosurgery Systems
    - 3.1.1.4.1. Linear Accelerator Radiosurgery Systems
    - 3.1.1.4.2. Gamma Knife Radiosurgery Systems
  - 3.1.1.5. Dura Substitutes
    - 3.1.1.5.1. Biological Dura Substitutes
    - 3.1.1.5.2. Synthetic Dura Substitutes
  - 3.1.1.6. Neurosurgical Ablation Devices
    - 3.1.1.6.1. MRI Guided Focused Ultrasound Systems
    - 3.1.1.6.2. MRI Guided Laser Therapy Systems
    - 3.1.1.6.3. MRI Guided RF Ablation Systems
  - 3.1.1.7. Neurosurgery Instruments
    - 3.1.1.7.1. Tissue Retractors
    - 3.1.1.7.2. Forceps
    - 3.1.1.7.3. Head Frames
    - 3.1.1.7.4. Cervical Plating systems
    - 3.1.1.7.5. Perforators
3.2. Global Neurosurgery Market Outlook, by End User, Value (US$ Bn), 2019-2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Hospitals
  - 3.2.1.2. Ambulatory Surgical Centers
  - 3.2.1.3. Specialized Neurological Institutes
3.3. Global Neurosurgery Market Outlook, by Region, Value (US$ Bn), 2019-2031
- 3.3.1. Key Highlights
  - 3.3.1.1. North America
  - 3.3.1.2. Europe
  - 3.3.1.3. Asia Pacific
  - 3.3.1.4. Latin America
  - 3.3.1.5. Middle East & Africa

4. North America Neurosurgery Market Outlook, 2019-2031

4.1. North America Neurosurgery Market Outlook, by Product, Value (US$ Bn), 2019-2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Neuro Interventional Devices
    - 4.1.1.1.1. Neurovascular Embolization Devices
      - 4.1.1.1.1.1. Embolization Coils
      - 4.1.1.1.1.2. Liquid Embolic Systems
      - 4.1.1.1.1.3. Flow Diversion Stents
      - 4.1.1.1.1.4. Aneurysm Clips
    - 4.1.1.1.2. Neurovascular Coiling Assist Devices
      - 4.1.1.1.2.1. Coiling Assist Stents
      - 4.1.1.1.2.2. Coiling Assist Balloons
    - 4.1.1.1.3. Neurovascular Thrombectomy Devices
      - 4.1.1.1.3.1. Stent Retrievers
      - 4.1.1.1.3.2. Aspiration Retrievers
    - 4.1.1.1.4. Microguidewires
    - 4.1.1.1.5. Microcatheters
    - 4.1.1.1.6. Support Catheters
    - 4.1.1.1.7. Intracranial Stents
  - 4.1.1.2. Neuroendoscopes
    - 4.1.1.2.1. Flexible Neuroendoscopes
    - 4.1.1.2.2. Rigid Neuroendoscopes
  - 4.1.1.3. Neurosurgical Drills
    - 4.1.1.3.1. Pneumatic Neurosurgical Drills
    - 4.1.1.3.2. Electrical Neurosurgical Drills
  - 4.1.1.4. Radiosurgery Systems
    - 4.1.1.4.1. Linear Accelerator Radiosurgery Systems
    - 4.1.1.4.2. Gamma Knife Radiosurgery Systems
  - 4.1.1.5. Dura Substitutes
    - 4.1.1.5.1. Biological Dura Substitutes
    - 4.1.1.5.2. Synthetic Dura Substitutes
  - 4.1.1.6. Neurosurgical Ablation Devices
    - 4.1.1.6.1. MRI Guided Focused Ultrasound Systems
    - 4.1.1.6.2. MRI Guided Laser Therapy Systems
    - 4.1.1.6.3. MRI Guided RF Ablation Systems
  - 4.1.1.7. Neurosurgery Instruments
    - 4.1.1.7.1. Tissue Retractors
    - 4.1.1.7.2. Forceps
    - 4.1.1.7.3. Head Frames
    - 4.1.1.7.4. Cervical Plating systems
    - 4.1.1.7.5. Perforators
4.2. North America Neurosurgery Market Outlook, by End User, Value (US$ Bn), 2019-2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Hospitals
  - 4.2.1.2. Ambulatory Surgical Centers
  - 4.2.1.3. Specialized Neurological Institutes
4.3. North America Neurosurgery Market Outlook, by Country, Value (US$ Bn), 2019-2031
- 4.3.1. Key Highlights
  - 4.3.1.1. U.S. Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 4.3.1.2. U.S. Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
  - 4.3.1.3. Canada Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 4.3.1.4. Canada Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
- 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Neurosurgery Market Outlook, 2019-2031

5.1. Europe Neurosurgery Market Outlook, by Product, Value (US$ Bn), 2019-2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Neuro Interventional Devices
    - 5.1.1.1.1. Neurovascular Embolization Devices
      - 5.1.1.1.1.1. Embolization Coils
      - 5.1.1.1.1.2. Liquid Embolic Systems
      - 5.1.1.1.1.3. Flow Diversion Stents
      - 5.1.1.1.1.4. Aneurysm Clips
    - 5.1.1.1.2. Neurovascular Coiling Assist Devices
      - 5.1.1.1.2.1. Coiling Assist Stents
      - 5.1.1.1.2.2. Coiling Assist Balloons
    - 5.1.1.1.3. Neurovascular Thrombectomy Devices
      - 5.1.1.1.3.1. Stent Retrievers
      - 5.1.1.1.3.2. Aspiration Retrievers
    - 5.1.1.1.4. Microguidewires
    - 5.1.1.1.5. Microcatheters
    - 5.1.1.1.6. Support Catheters
    - 5.1.1.1.7. Intracranial Stents
  - 5.1.1.2. Neuroendoscopes
    - 5.1.1.2.1. Flexible Neuroendoscopes
    - 5.1.1.2.2. Rigid Neuroendoscopes
  - 5.1.1.3. Neurosurgical Drills
    - 5.1.1.3.1. Pneumatic Neurosurgical Drills
    - 5.1.1.3.2. Electrical Neurosurgical Drills
  - 5.1.1.4. Radiosurgery Systems
    - 5.1.1.4.1. Linear Accelerator Radiosurgery Systems
    - 5.1.1.4.2. Gamma Knife Radiosurgery Systems
  - 5.1.1.5. Dura Substitutes
    - 5.1.1.5.1. Biological Dura Substitutes
    - 5.1.1.5.2. Synthetic Dura Substitutes
  - 5.1.1.6. Neurosurgical Ablation Devices
    - 5.1.1.6.1. MRI Guided Focused Ultrasound Systems
    - 5.1.1.6.2. MRI Guided Laser Therapy Systems
    - 5.1.1.6.3. MRI Guided RF Ablation Systems
  - 5.1.1.7. Neurosurgery Instruments
    - 5.1.1.7.1. Tissue Retractors
    - 5.1.1.7.2. Forceps
    - 5.1.1.7.3. Head Frames
    - 5.1.1.7.4. Cervical Plating systems
    - 5.1.1.7.5. Perforators
5.2. Europe Neurosurgery Market Outlook, by End User, Value (US$ Bn), 2019-2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Hospitals
  - 5.2.1.2. Ambulatory Surgical Centers
  - 5.2.1.3. Specialized Neurological Institutes
5.3. Europe Neurosurgery Market Outlook, by Country, Value (US$ Bn), 2019-2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Germany Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 5.3.1.2. Germany Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
  - 5.3.1.3. U.K. Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 5.3.1.4. U.K. Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
  - 5.3.1.5. France Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 5.3.1.6. France Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
  - 5.3.1.7. Italy Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 5.3.1.8. Italy Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
  - 5.3.1.9. Turkey Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 5.3.1.10. Turkey Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
  - 5.3.1.11. Russia Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 5.3.1.12. Russia Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
  - 5.3.1.13. Rest of Europe Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 5.3.1.14. Rest of Europe Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
- 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Neurosurgery Market Outlook, 2019-2031

6.1. Asia Pacific Neurosurgery Market Outlook, by Product, Value (US$ Bn), 2019-2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Neuro Interventional Devices
    - 6.1.1.1.1. Neurovascular Embolization Devices
      - 6.1.1.1.1.1. Embolization Coils
      - 6.1.1.1.1.2. Liquid Embolic Systems
      - 6.1.1.1.1.3. Flow Diversion Stents
      - 6.1.1.1.1.4. Aneurysm Clips
    - 6.1.1.1.2. Neurovascular Coiling Assist Devices
      - 6.1.1.1.2.1. Coiling Assist Stents
      - 6.1.1.1.2.2. Coiling Assist Balloons
    - 6.1.1.1.3. Neurovascular Thrombectomy Devices
      - 6.1.1.1.3.1. Stent Retrievers
      - 6.1.1.1.3.2. Aspiration Retrievers
    - 6.1.1.1.4. Microguidewires
    - 6.1.1.1.5. Microcatheters
    - 6.1.1.1.6. Support Catheters
    - 6.1.1.1.7. Intracranial Stents
  - 6.1.1.2. Neuroendoscopes
    - 6.1.1.2.1. Flexible Neuroendoscopes
    - 6.1.1.2.2. Rigid Neuroendoscopes
  - 6.1.1.3. Neurosurgical Drills
    - 6.1.1.3.1. Pneumatic Neurosurgical Drills
    - 6.1.1.3.2. Electrical Neurosurgical Drills
  - 6.1.1.4. Radiosurgery Systems
    - 6.1.1.4.1. Linear Accelerator Radiosurgery Systems
    - 6.1.1.4.2. Gamma Knife Radiosurgery Systems
  - 6.1.1.5. Dura Substitutes
    - 6.1.1.5.1. Biological Dura Substitutes
    - 6.1.1.5.2. Synthetic Dura Substitutes
  - 6.1.1.6. Neurosurgical Ablation Devices
    - 6.1.1.6.1. MRI Guided Focused Ultrasound Systems
    - 6.1.1.6.2. MRI Guided Laser Therapy Systems
    - 6.1.1.6.3. MRI Guided RF Ablation Systems
  - 6.1.1.7. Neurosurgery Instruments
    - 6.1.1.7.1. Tissue Retractors
    - 6.1.1.7.2. Forceps
    - 6.1.1.7.3. Head Frames
    - 6.1.1.7.4. Cervical Plating systems
    - 6.1.1.7.5. Perforators
6.2. Asia Pacific Neurosurgery Market Outlook, by End User, Value (US$ Bn), 2019-2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Hospitals
  - 6.2.1.2. Ambulatory Surgical Centers
  - 6.2.1.3. Specialized Neurological Institutes
- 6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Neurosurgery Market Outlook, by Country, Value (US$ Bn), 2019-2031
- 6.3.1. Key Highlights
  - 6.3.1.1. China Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 6.3.1.2. China Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
  - 6.3.1.3. Japan Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 6.3.1.4. Japan Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
  - 6.3.1.5. South Korea Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 6.3.1.6. South Korea Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
  - 6.3.1.7. India Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 6.3.1.8. India Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
  - 6.3.1.9. Southeast Asia Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 6.3.1.10. Southeast Asia Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
  - 6.3.1.11. Rest of Asia Pacific Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 6.3.1.12. Rest of Asia Pacific Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
- 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Neurosurgery Market Outlook, 2019-2031

7.1. Latin America Neurosurgery Market Outlook, by Product, Value (US$ Bn), 2019-2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Neuro Interventional Devices
    - 7.1.1.1.1. Neurovascular Embolization Devices
      - 7.1.1.1.1.1. Embolization Coils
      - 7.1.1.1.1.2. Liquid Embolic Systems
      - 7.1.1.1.1.3. Flow Diversion Stents
      - 7.1.1.1.1.4. Aneurysm Clips
    - 7.1.1.1.2. Neurovascular Coiling Assist Devices
      - 7.1.1.1.2.1. Coiling Assist Stents
      - 7.1.1.1.2.2. Coiling Assist Balloons
    - 7.1.1.1.3. Neurovascular Thrombectomy Devices
      - 7.1.1.1.3.1. Stent Retrievers
      - 7.1.1.1.3.2. Aspiration Retrievers
    - 7.1.1.1.4. Microguidewires
    - 7.1.1.1.5. Microcatheters
    - 7.1.1.1.6. Support Catheters
    - 7.1.1.1.7. Intracranial Stents
  - 7.1.1.2. Neuroendoscopes
    - 7.1.1.2.1. Flexible Neuroendoscopes
    - 7.1.1.2.2. Rigid Neuroendoscopes
  - 7.1.1.3. Neurosurgical Drills
    - 7.1.1.3.1. Pneumatic Neurosurgical Drills
    - 7.1.1.3.2. Electrical Neurosurgical Drills
  - 7.1.1.4. Radiosurgery Systems
    - 7.1.1.4.1. Linear Accelerator Radiosurgery Systems
    - 7.1.1.4.2. Gamma Knife Radiosurgery Systems
  - 7.1.1.5. Dura Substitutes
    - 7.1.1.5.1. Biological Dura Substitutes
    - 7.1.1.5.2. Synthetic Dura Substitutes
  - 7.1.1.6. Neurosurgical Ablation Devices
    - 7.1.1.6.1. MRI Guided Focused Ultrasound Systems
    - 7.1.1.6.2. MRI Guided Laser Therapy Systems
    - 7.1.1.6.3. MRI Guided RF Ablation Systems
  - 7.1.1.7. Neurosurgery Instruments
    - 7.1.1.7.1. Tissue Retractors
    - 7.1.1.7.2. Forceps
    - 7.1.1.7.3. Head Frames
    - 7.1.1.7.4. Cervical Plating systems
    - 7.1.1.7.5. Perforators
7.2. Latin America Neurosurgery Market Outlook, by End User, Value (US$ Bn), 2019-2031
- 7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Neurosurgery Market Outlook, by Country, Value (US$ Bn), 2019-2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Brazil Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 7.3.1.2. Brazil Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
  - 7.3.1.3. Mexico Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 7.3.1.4. Mexico Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
  - 7.3.1.5. Argentina Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 7.3.1.6. Argentina Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
  - 7.3.1.7. Rest of Latin America Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 7.3.1.8. Rest of Latin America Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
- 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Neurosurgery Market Outlook, 2019-2031

8.1. Middle East & Africa Neurosurgery Market Outlook, by Product, Value (US$ Bn), 2019-2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Neuro Interventional Devices
    - 8.1.1.1.1. Neurovascular Embolization Devices
      - 8.1.1.1.1.1. Embolization Coils
      - 8.1.1.1.1.2. Liquid Embolic Systems
      - 8.1.1.1.1.3. Flow Diversion Stents
      - 8.1.1.1.1.4. Aneurysm Clips
    - 8.1.1.1.2. Neurovascular Coiling Assist Devices
      - 8.1.1.1.2.1. Coiling Assist Stents
      - 8.1.1.1.2.2. Coiling Assist Balloons
    - 8.1.1.1.3. Neurovascular Thrombectomy Devices
      - 8.1.1.1.3.1. Stent Retrievers
      - 8.1.1.1.3.2. Aspiration Retrievers
    - 8.1.1.1.4. Microguidewires
    - 8.1.1.1.5. Microcatheters
    - 8.1.1.1.6. Support Catheters
    - 8.1.1.1.7. Intracranial Stents
  - 8.1.1.2. Neuroendoscopes
    - 8.1.1.2.1. Flexible Neuroendoscopes
    - 8.1.1.2.2. Rigid Neuroendoscopes
  - 8.1.1.3. Neurosurgical Drills
    - 8.1.1.3.1. Pneumatic Neurosurgical Drills
    - 8.1.1.3.2. Electrical Neurosurgical Drills
  - 8.1.1.4. Radiosurgery Systems
    - 8.1.1.4.1. Linear Accelerator Radiosurgery Systems
    - 8.1.1.4.2. Gamma Knife Radiosurgery Systems
  - 8.1.1.5. Dura Substitutes
    - 8.1.1.5.1. Biological Dura Substitutes
    - 8.1.1.5.2. Synthetic Dura Substitutes
  - 8.1.1.6. Neurosurgical Ablation Devices
    - 8.1.1.6.1. MRI Guided Focused Ultrasound Systems
    - 8.1.1.6.2. MRI Guided Laser Therapy Systems
    - 8.1.1.6.3. MRI Guided RF Ablation Systems
  - 8.1.1.7. Neurosurgery Instruments
    - 8.1.1.7.1. Tissue Retractors
    - 8.1.1.7.2. Forceps
    - 8.1.1.7.3. Head Frames
    - 8.1.1.7.4. Cervical Plating systems
    - 8.1.1.7.5. Perforators
8.2. Middle East & Africa Neurosurgery Market Outlook, by End User, Value (US$ Bn), 2019-2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Hospitals
  - 8.2.1.2. Ambulatory Surgical Centers
  - 8.2.1.3. Specialized Neurological Institutes
- 8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Neurosurgery Market Outlook, by Country, Value (US$ Bn), 2019-2031
- 8.3.1. Key Highlights
  - 8.3.1.1. GCC Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 8.3.1.2. GCC Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
  - 8.3.1.3. South Africa Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 8.3.1.4. South Africa Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
  - 8.3.1.5. Egypt Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 8.3.1.6. Egypt Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
  - 8.3.1.7. Nigeria Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 8.3.1.8. Nigeria Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
  - 8.3.1.9. Rest of Middle East & Africa Neurosurgery Market by Product, Value (US$ Bn), 2019-2031
  - 8.3.1.10. Rest of Middle East & Africa Neurosurgery Market by End User, Value (US$ Bn), 2019-2031
- 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Company Market Share Analysis, 2024
9.2. Competitive Dashboard
9.3. Company Profiles
- 9.3.1. B. Braun Melsungen AG
  - 9.3.1.1. Company Overview
  - 9.3.1.2. Therapy Portfolio
  - 9.3.1.3. Financial Overview
  - 9.3.1.4. Business Strategies and Development
- 9.3.2. Medtronic plc
  - 9.3.2.1. Company Overview
  - 9.3.2.2. Therapy Portfolio
  - 9.3.2.3. Financial Overview
  - 9.3.2.4. Business Strategies and Development
- 9.3.3. DePuy Synthes
  - 9.3.3.1. Company Overview
  - 9.3.3.2. Therapy Portfolio
  - 9.3.3.3. Financial Overview
  - 9.3.3.4. Business Strategies and Development
- 9.3.4. Boston Scientific
  - 9.3.4.1. Company Overview
  - 9.3.4.2. Therapy Portfolio
  - 9.3.4.3. Financial Overview
  - 9.3.4.4. Business Strategies and Development
- 9.3.5. Stryker Corp.
  - 9.3.5.1. Company Overview
  - 9.3.5.2. Therapy Portfolio
  - 9.3.5.3. Financial Overview
  - 9.3.5.4. Business Strategies and Development
- 9.3.6. Terumo Corporation
  - 9.3.6.1. Company Overview
  - 9.3.6.2. Therapy Portfolio
  - 9.3.6.3. Financial Overview
  - 9.3.6.4. Business Strategies and Development
- 9.3.7. KARL STORZ GmbH & Co KG
  - 9.3.7.1. Company Overview
  - 9.3.7.2. Therapy Portfolio
  - 9.3.7.3. Financial Overview
  - 9.3.7.4. Business Strategies and Development
- 9.3.8. Integra LifeSciences
  - 9.3.8.1. Company Overview
  - 9.3.8.2. Therapy Portfolio
  - 9.3.8.3. Financial Overview
  - 9.3.8.4. Business Strategies and Development
- 9.3.9. Penumbra Inc
  - 9.3.9.1. Company Overview
  - 9.3.9.2. Therapy Portfolio
  - 9.3.9.3. Financial Overview
  - 9.3.9.4. Business Strategies and Development
- 9.3.10. Adeor Medical AG
  - 9.3.10.1. Company Overview
  - 9.3.10.2. Therapy Portfolio
  - 9.3.10.3. Financial Overview
  - 9.3.10.4. Business Strategies and Development
- 9.3.11. Others
  - 9.3.11.1. Company Overview
  - 9.3.11.2. Therapy Portfolio
  - 9.3.11.3. Financial Overview
  - 9.3.11.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations